An Isoform of the Oncogenic Splice Variant AIMP2-DX2 Detected by a Novel Monoclonal Antibody

An Isoform of the Oncogenic Splice Variant AIMP2-DX2 Detected by a Novel Monoclonal Antibody

AIMP2-DX2, an exon 2-deleted splice variant of AIMP2 (aminoacyl-tRNA synthetase-interacting multifunctional protein 2), is highly expressed in lung cancer and involved in tumor progression in vivo. Oncogenic function of AIMP2-DX2 and its correlation with poor prognosis of cancer patients have been w...

Full description

Bibliographic Details
Main Authors:	Dae Gyu Kim, Thi Thu Ha Nguyen, Nam Hoon Kwon, Junsik Sung, Semi Lim, Eun-Joo Kang, Jihye Lee, Woo Young Seo, Arum Kim, Yoon Soo Chang, Hyunbo Shim, Sunghoon Kim
Format:	Article
Language:	English
Published:	MDPI AG 2020-05-01
Series:	Biomolecules
Subjects:	antibody splice variant AIMP2-DX2 phage display diagnostic marker
Online Access:	https://www.mdpi.com/2218-273X/10/6/820

Similar Items

Anticancer Activity of Pyrimethamine via Ubiquitin Mediated Degradation of AIMP2-DX2
by: Dae Gyu Kim, et al.
Published: (2020-06-01)

Data on optimization of expression and purification of AIMP2-DX2 protein in Escherichia coli
by: Roshan Jha, et al.
Published: (2017-04-01)

Synthesis and discovery of the first potent proteolysis targeting chimaera (PROTAC) degrader of AIMP2-DX2 as a lung cancer drug
by: BoRa Lee, et al.
Published: (2023-12-01)

Bi-directional regulation of AIMP2 and its splice variant on PARP-1-dependent neuronal cell death; Therapeutic implication for Parkinson's disease
by: Min Hak Lee, et al.
Published: (2024-01-01)

An extensive in silico analysis of missense mutations of the human AIMP2 gene
by: Shima Farrokhi, et al.
Published: (2024-10-01)

Brain-targeted delivery of neuroprotective survival gene minimizing hematopoietic cell contamination: implications for Parkinson’s disease treatment
by: Min Hak Lee, et al.
Published: (2024-01-01)

AIMP2 accumulation in brain leads to cognitive deficits and blood secretion in Parkinson’s disease
by: Heejeong Kim, et al.
Published: (2024-10-01)

Rare Neurologic Disease-Associated Mutations of AIMP1 Are Related with Inhibitory Neuronal Differentiation Which Is Reversed by Ibuprofen
by: Yu Takeuchi, et al.
Published: (2020-05-01)

AIMp1 Potentiates TH1 Polarization and Is Critical for Effective Antitumor and Antiviral Immunity
by: Dan Liang, et al.
Published: (2018-01-01)

Functional Fragments of AIMP1-Derived Peptide (AdP) and Optimized Hydrosol for Their Topical Deposition by Box-Behnken Design
by: Jeong-Jun Lee, et al.
Published: (2019-05-01)

Unraveling the Binding Mode of Cyclic Adenosine–Inosine Monophosphate (cAIMP) to STING through Molecular Dynamics Simulations
by: Meiting Wang, et al.
Published: (2024-06-01)

BACTERIAL EXPRESSION OPTIMIZATION OF HUMAN AIMP1/Р43 RECOMBINANT PROTEIN – A COMPONENT OF HUMAN MULTISYNTHETASE COMPLEX IN STRAIN OF ESCHERICHIA COLI BL21(DE3)RIL
by: Н. В. Воробйова, et al.
Published: (2015-12-01)

AIMP2-DX2 provides therapeutic interface to control KRAS-driven tumorigenesis
by: Dae Gyu Kim, et al.
Published: (2022-05-01)

Arquitectura de un Juego en 2D para Android y IOS Usando Cocos2DX
by: Luis Felipe Wanumen-Silva, et al.
Published: (2022-04-01)

The therapeutic effect of DX2 inhibition in nicotine-induced lung cancer progression
by: Soyoung Park, et al.
Published: (2024-12-01)

AIMP1 promotes multiple myeloma malignancy through interacting with ANP32A to mediate histone H3 acetylation
by: Rongfang Wei, et al.
Published: (2022-11-01)

Role of the T2Dx magnetic resonance assay in patients with suspected bloodstream infection: a single-centre real-world experience
by: Angela Quirino, et al.
Published: (2022-02-01)

Editorial: The role of inflammation in neurodegenerative diseases
by: Egor Dzyubenko, et al.
Published: (2023-04-01)

Identification and evaluation of midbrain specific longevity-related genes in exceptionally long-lived but healthy mice
by: Hyojung Kim, et al.
Published: (2023-01-01)

Anti-aminoacyl-tRNA synthetase-interacting multifunctional protein-1 antibody improves airway inflammation in mice with house dust mite induced asthma
by: Sung-Ryeol Kim, MD, et al.
Published: (2024-09-01)

How Canadian Oncologists Use Oncotype DX for Treatment of Breast Cancer Patients
by: Xiaofu Zhu, et al.
Published: (2021-02-01)

Spotlight on the utility of the Oncotype DX® breast cancer assay
by: Siow ZR, et al.
Published: (2018-02-01)

HER2DX genomic test in HER2-positive/hormone receptor-positive breast cancer treated with neoadjuvant trastuzumab and pertuzumab: A correlative analysis from the PerELISA trialResearch in context
by: Valentina Guarneri, et al.
Published: (2022-11-01)

Aminoacyl transfer ribonucleic acid synthetase complex-interacting multifunctional protein 1 induces microglial activation and M1 polarization via the mitogen-activated protein kinase/nuclear factor-kappa B signaling pathway
by: Yebin Oh, et al.
Published: (2022-09-01)

Diagnostic value of combined CT lymphangiography and 99Tcm-DX lymphoscintigraphy in primary chylopericardium
by: Yimeng Zhang, et al.
Published: (2024-08-01)

Impact of Oncotype DX testing on ER+ breast cancer treatment and survival in the first decade of use
by: Evelien Schaafsma, et al.
Published: (2021-07-01)

Patient and physician factors associated with Oncotype DX and adjuvant chemotherapy utilization for breast cancer patients in New Hampshire, 2010–2016
by: Thomas M. Schwedhelm, et al.
Published: (2020-09-01)

Protectin DX Relieve Hyperoxia‐induced Lung Injury by Protecting Pulmonary Endothelial Glycocalyx
by: Liang Z, et al.
Published: (2023-02-01)

Does Mode of Surgical Intervention Based on Oncotype DX Score Influence Disease Recurrence in Early Breast Cancer?
by: T. M. Aherne, et al.
Published: (2020-04-01)

Does Pre-Emptive Availability of PREDICT 2.1 Results Change Ordering Practices for Oncotype DX? A Multi-Center Prospective Cohort Study
by: Arif Ali Awan, et al.
Published: (2024-02-01)

A 10 year service evaluation of the survival of 439 patients with early oestrogen receptor positive breast cancer who underwent initial OncotypeDX ® testing to guide adjuvant chemotherapy decisions
by: Asma Munir, et al.
Published: (2023-01-01)

iSCAN-V2: A One-Pot RT-RPA–CRISPR/Cas12b Assay for Point-of-Care SARS-CoV-2 Detection
by: Rashid Aman, et al.
Published: (2022-01-01)

Analytical Validation of NavDx, a cfDNA-Based Fragmentomic Profiling Assay for HPV-Driven Cancers
by: Alicia Gunning, et al.
Published: (2023-02-01)

The incidence of unfilled second mesiobuccal canals and periapical lesions in maxillary molars by cone-beam computed tomography E-VOL DX software
by: Matheus Albino Souza, et al.
Published: (2024-01-01)

DxR Clinician - Congenital Defect Case (Out of Print)
by: Hurley Myers
Published: (2006-09-01)

Protectin DX Exhibits Protective Effects in Mouse Model of Lipopolysaccharide-Induced Acute Lung Injury
by: Wen Tan, et al.
Published: (2018-01-01)

The Oncotype Dx Assay in ER-Positive, HER2-Negative Breast Cancer Patients: A Real Life Experience from a Single Cancer Center
by: Stephane Thibodeau, et al.
Published: (2019-07-01)

Validity of BiliDx as a point-of-care bilirubin measurement device to diagnose and monitor neonatal jaundice at Muhimbili National Hospital, an observational study
by: Pascal Clemence, et al.
Published: (2024-02-01)

Correlations Between Oncotype DX Recurrence Score and Classic Risk Factors in Early Breast Cancer: Results of A Prospective Multicenter Study in Turkey
by: Vahit Özmen, et al.
Published: (2016-07-01)

Ct values as a diagnostic tool for monitoring SARS-CoV-2 viral load using the QIAstat-Dx® Respiratory SARS-CoV-2 Panel
by: Martí Juanola-Falgarona, et al.
Published: (2022-09-01)